Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Maurizio Zangari

Concepts (496)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
151
2025
3013
10.030
Why?
Thalidomide
33
2016
376
2.850
Why?
Boronic Acids
17
2013
180
2.690
Why?
Pyrazines
17
2013
187
2.670
Why?
Bone Marrow
17
2022
354
1.810
Why?
Hematopoietic Stem Cell Transplantation
21
2024
600
1.770
Why?
Venous Thrombosis
8
2009
89
1.610
Why?
Antineoplastic Combined Chemotherapy Protocols
31
2024
1020
1.610
Why?
Paraproteinemias
7
2022
72
1.520
Why?
Angiogenesis Inhibitors
12
2009
183
1.460
Why?
Humans
165
2025
52441
1.330
Why?
Antibodies, Bispecific
7
2025
104
1.320
Why?
Protease Inhibitors
7
2011
60
1.270
Why?
Chromosomes, Human, Pair 1
7
2023
95
1.240
Why?
Prognosis
42
2025
2100
1.200
Why?
Proteasome Inhibitors
6
2016
101
1.200
Why?
Middle Aged
70
2025
13133
1.160
Why?
Aged
67
2025
10242
1.160
Why?
Neoplasm, Residual
7
2025
169
1.120
Why?
Antineoplastic Agents
20
2024
1216
1.110
Why?
Alkaline Phosphatase
7
2020
92
1.090
Why?
Thrombosis
6
2013
250
1.010
Why?
Transplantation, Autologous
29
2024
479
1.000
Why?
Bone Remodeling
3
2016
151
0.980
Why?
Bone Diseases
2
2021
91
0.980
Why?
Monoclonal Gammopathy of Undetermined Significance
9
2025
123
0.930
Why?
Male
77
2025
26874
0.920
Why?
Female
76
2025
28277
0.910
Why?
Osteogenesis
4
2018
368
0.890
Why?
Gene Expression Profiling
22
2025
1099
0.860
Why?
Immunologic Factors
5
2016
114
0.850
Why?
Anticoagulants
6
2009
276
0.780
Why?
Peripheral Blood Stem Cell Transplantation
6
2012
58
0.780
Why?
Neoplasms, Plasma Cell
4
2024
35
0.770
Why?
Melphalan
12
2016
176
0.770
Why?
Activated Protein C Resistance
4
2011
10
0.740
Why?
Adult
45
2025
14205
0.730
Why?
Parathyroid Hormone
4
2018
143
0.710
Why?
Antibodies, Monoclonal
4
2022
475
0.690
Why?
Venous Thromboembolism
3
2011
80
0.690
Why?
Plasma Cells
10
2025
233
0.660
Why?
Aged, 80 and over
23
2025
3449
0.660
Why?
Durapatite
1
2020
23
0.660
Why?
B-Cell Maturation Antigen
7
2025
95
0.650
Why?
Disease-Free Survival
21
2019
461
0.630
Why?
Thromboembolism
3
2009
48
0.630
Why?
Gene Amplification
1
2019
59
0.630
Why?
Survival Rate
21
2020
944
0.620
Why?
Neoplasm Proteins
7
2020
328
0.620
Why?
Dexamethasone
14
2024
434
0.620
Why?
Retrospective Studies
26
2025
6694
0.620
Why?
Myeloablative Agonists
4
2012
32
0.610
Why?
Disease Progression
17
2025
870
0.580
Why?
Gene Expression Regulation, Neoplastic
12
2021
853
0.580
Why?
Bone and Bones
4
2021
492
0.570
Why?
Factor V
4
2011
10
0.570
Why?
Oligopeptides
3
2018
94
0.570
Why?
Spinal Fractures
1
2018
38
0.570
Why?
Thymus Gland
1
2018
40
0.560
Why?
Parathyroidectomy
1
2018
46
0.550
Why?
Thyroidectomy
1
2018
61
0.540
Why?
Translocation, Genetic
8
2021
266
0.540
Why?
Clinical Trials as Topic
9
2022
461
0.540
Why?
Chromosome Aberrations
11
2023
295
0.530
Why?
Treatment Outcome
31
2022
5508
0.520
Why?
Survival Analysis
14
2024
656
0.520
Why?
Calcification, Physiologic
1
2017
42
0.520
Why?
Follow-Up Studies
22
2024
2294
0.520
Why?
Pelvis
1
2017
65
0.510
Why?
Risk Factors
23
2024
3971
0.510
Why?
Stem Cell Transplantation
11
2023
188
0.500
Why?
Osteoblasts
6
2020
478
0.500
Why?
Thrombophilia
4
2009
18
0.490
Why?
Tumor Microenvironment
5
2024
257
0.470
Why?
Chromosome Deletion
6
2023
138
0.460
Why?
Drug Resistance, Neoplasm
7
2015
336
0.450
Why?
Animals
19
2024
13485
0.440
Why?
Neoplasms
3
2009
1314
0.440
Why?
Transplantation Conditioning
7
2019
93
0.430
Why?
Neoplasm Recurrence, Local
7
2024
639
0.420
Why?
Receptor, Parathyroid Hormone, Type 1
1
2013
21
0.420
Why?
Polycythemia Vera
1
2013
6
0.400
Why?
Positron-Emission Tomography
4
2025
297
0.400
Why?
Hemostasis
3
2008
54
0.400
Why?
Neovascularization, Pathologic
4
2009
158
0.390
Why?
Diffusion Magnetic Resonance Imaging
3
2025
131
0.390
Why?
Mutation
6
2022
1331
0.380
Why?
Combined Modality Therapy
17
2024
641
0.380
Why?
Neutropenia
2
2023
113
0.370
Why?
Hematopoietic Stem Cells
2
2012
180
0.350
Why?
Bone Neoplasms
2
2010
188
0.340
Why?
Evolution, Molecular
2
2021
98
0.330
Why?
Amyloidosis
3
2009
85
0.330
Why?
Doxorubicin
7
2009
246
0.320
Why?
Immunotherapy, Adoptive
4
2024
156
0.320
Why?
Mice
11
2024
5899
0.310
Why?
Anti-Anxiety Agents
1
2009
33
0.310
Why?
In Situ Hybridization, Fluorescence
7
2023
262
0.310
Why?
Kaplan-Meier Estimate
10
2019
485
0.300
Why?
Hemorrhagic Disorders
1
2009
6
0.300
Why?
Cryoglobulinemia
1
2008
13
0.300
Why?
Pain
2
2009
373
0.290
Why?
Biopsy, Needle
1
2009
181
0.290
Why?
Pulmonary Embolism
1
2009
81
0.280
Why?
Analgesics
1
2009
106
0.280
Why?
Recurrence
11
2024
680
0.280
Why?
Collagen
2
2020
215
0.280
Why?
Risk Assessment
7
2023
1349
0.280
Why?
Hematologic Neoplasms
2
2022
101
0.270
Why?
Cell Line, Tumor
4
2023
1429
0.270
Why?
Farnesyltranstransferase
1
2006
4
0.260
Why?
Vascular Endothelial Growth Factor Receptor-2
2
2004
38
0.260
Why?
Waldenstrom Macroglobulinemia
2
2022
38
0.260
Why?
Osteolysis
2
2022
74
0.260
Why?
Pyrroles
2
2004
73
0.250
Why?
Risk
4
2014
315
0.250
Why?
Neoplasms, Second Primary
2
2024
75
0.250
Why?
Cell Differentiation
4
2022
667
0.250
Why?
Cell Proliferation
8
2023
1013
0.250
Why?
Time Factors
11
2021
2987
0.250
Why?
Sirolimus
1
2006
72
0.250
Why?
Logistic Models
5
2018
930
0.250
Why?
Signal Transduction
6
2021
1724
0.240
Why?
Chromosomes, Human, Pair 17
2
2017
35
0.240
Why?
Fluorodeoxyglucose F18
4
2021
181
0.230
Why?
Plasmacytoma
2
2020
44
0.220
Why?
Immunoglobulins, Intravenous
1
2025
63
0.220
Why?
Enoxaparin
1
2004
31
0.220
Why?
Polycomb Repressive Complex 2
2
2021
47
0.220
Why?
Remission Induction
10
2021
218
0.220
Why?
Indoles
2
2004
283
0.210
Why?
Vascular Endothelial Growth Factor A
2
2004
186
0.210
Why?
Prospective Studies
9
2019
2433
0.200
Why?
Blood Coagulation
1
2003
64
0.200
Why?
Bone Resorption
2
2022
300
0.190
Why?
Proto-Oncogene Proteins B-raf
2
2020
75
0.190
Why?
Hematopoietic Stem Cell Mobilization
3
2008
60
0.190
Why?
Immunoglobulin Light Chains
2
2017
90
0.190
Why?
Drug Approval
1
2022
39
0.190
Why?
Immunoconjugates
1
2022
37
0.180
Why?
Randomized Controlled Trials as Topic
3
2012
625
0.180
Why?
Cell Cycle
2
2021
236
0.180
Why?
Hemorrhage
3
2009
225
0.180
Why?
Lymphoma, B-Cell
1
2022
60
0.180
Why?
Chromosomal Instability
2
2019
16
0.180
Why?
Patient Participation
1
2022
65
0.180
Why?
Epigenomics
1
2021
75
0.180
Why?
Chromosomes, Human, Pair 13
5
2008
38
0.180
Why?
T-Lymphocytes
4
2024
318
0.170
Why?
SOXC Transcription Factors
1
2021
13
0.170
Why?
Arkansas
5
2021
2013
0.170
Why?
Calcium Phosphates
1
2020
5
0.170
Why?
Odontoblasts
1
2020
4
0.170
Why?
HL-60 Cells
1
2020
19
0.170
Why?
U937 Cells
1
2020
14
0.170
Why?
Etoposide
5
2009
70
0.170
Why?
K562 Cells
1
2020
41
0.170
Why?
Genes, Tumor Suppressor
2
2021
73
0.170
Why?
NIH 3T3 Cells
1
2020
52
0.170
Why?
MCF-7 Cells
1
2020
63
0.160
Why?
Mammals
1
2020
59
0.160
Why?
Kidney Diseases
2
2020
230
0.160
Why?
Practice Guidelines as Topic
1
2023
498
0.160
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.160
Why?
Leukemia, Plasma Cell
1
2020
33
0.160
Why?
Protein C
2
2011
20
0.160
Why?
Myelodysplastic Syndromes
3
2007
86
0.160
Why?
beta 2-Microglobulin
5
2008
39
0.160
Why?
HeLa Cells
1
2020
243
0.160
Why?
Cisplatin
6
2009
282
0.160
Why?
HEK293 Cells
1
2020
236
0.160
Why?
Busulfan
1
2019
18
0.160
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.150
Why?
Atrial Fibrillation
1
2022
196
0.150
Why?
Gene Regulatory Networks
1
2020
112
0.150
Why?
Imaging, Three-Dimensional
2
2017
150
0.150
Why?
Epigenesis, Genetic
2
2020
396
0.150
Why?
Healthcare Disparities
1
2022
291
0.150
Why?
Genome-Wide Association Study
1
2020
184
0.150
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
9
0.150
Why?
Fractures, Compression
1
2018
17
0.150
Why?
Predictive Value of Tests
4
2009
938
0.150
Why?
Spleen
1
2019
166
0.140
Why?
Genomic Instability
2
2016
87
0.140
Why?
Fibrinolysis
2
2009
5
0.140
Why?
Phosphotransferases
1
2018
17
0.140
Why?
Cytokines
3
2007
622
0.140
Why?
Blood Coagulation Factors
2
2009
17
0.140
Why?
Antineoplastic Agents, Alkylating
6
2008
78
0.140
Why?
Bacteremia
1
2019
87
0.140
Why?
Adipocytes
1
2018
127
0.140
Why?
Cell Line
1
2020
1020
0.140
Why?
Gene Rearrangement
1
2018
76
0.130
Why?
Cluster Analysis
4
2012
236
0.130
Why?
Hexokinase
1
2017
16
0.130
Why?
Metaphase
4
2016
47
0.130
Why?
Heparin, Low-Molecular-Weight
2
2007
21
0.130
Why?
Ultrasonography, Doppler
2
2007
42
0.130
Why?
Renal Insufficiency
4
2010
109
0.130
Why?
Fibrinolytic Agents
2
2007
131
0.120
Why?
Calcium
1
2018
396
0.120
Why?
Clonal Evolution
1
2016
57
0.120
Why?
Gene Expression Regulation, Enzymologic
1
2017
180
0.120
Why?
Tumor Burden
3
2020
132
0.120
Why?
Gene Expression
1
2018
618
0.120
Why?
Disease Models, Animal
4
2016
1483
0.120
Why?
Immunotherapy
2
2016
251
0.120
Why?
Bone Marrow Transplantation
4
2022
110
0.120
Why?
Tumor Suppressor Protein p53
1
2017
224
0.120
Why?
Multivariate Analysis
7
2021
601
0.120
Why?
Genes, Neoplasm
1
2015
31
0.120
Why?
Polymorphism, Single Nucleotide
2
2020
506
0.110
Why?
Gene Dosage
1
2015
73
0.110
Why?
Salvage Therapy
6
2006
137
0.110
Why?
Incidence
2
2009
1096
0.110
Why?
Algorithms
1
2018
673
0.110
Why?
Transcriptome
3
2025
357
0.110
Why?
Osteoclasts
3
2022
423
0.100
Why?
Cystatin M
2
2024
17
0.100
Why?
Case-Control Studies
4
2011
1202
0.100
Why?
Tomography, X-Ray Computed
2
2017
1140
0.100
Why?
Altitude
1
2013
16
0.100
Why?
Janus Kinase 2
1
2013
23
0.100
Why?
Chromosomes, Human, Pair 11
3
2020
56
0.100
Why?
Cross-Sectional Studies
3
2023
1677
0.100
Why?
STAT3 Transcription Factor
2
2010
89
0.100
Why?
Models, Biological
1
2016
735
0.100
Why?
Protein-Tyrosine Kinases
3
2018
92
0.100
Why?
Bone Density Conservation Agents
2
2010
75
0.100
Why?
Mice, Inbred C57BL
1
2018
1888
0.100
Why?
Cytogenetic Analysis
6
2014
79
0.100
Why?
Creatinine
2
2010
156
0.100
Why?
Viremia
1
2012
23
0.090
Why?
Clone Cells
2
2023
76
0.090
Why?
Models, Genetic
2
2016
173
0.090
Why?
Cytomegalovirus Infections
1
2012
38
0.090
Why?
Clinical Trials, Phase II as Topic
1
2012
48
0.090
Why?
Clinical Trials, Phase III as Topic
1
2012
49
0.090
Why?
Viper Venoms
1
2011
7
0.090
Why?
Drug Evaluation, Preclinical
1
2012
141
0.090
Why?
Epidemiologic Methods
2
2008
47
0.090
Why?
NF-kappa B
2
2018
326
0.090
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
7
0.090
Why?
Arsenicals
1
2010
15
0.090
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
18
0.090
Why?
Oxides
1
2010
21
0.080
Why?
Mutation Rate
2
2021
36
0.080
Why?
Granulocyte Colony-Stimulating Factor
2
2008
64
0.080
Why?
Hypercalcemia
1
2010
34
0.080
Why?
Transplantation, Homologous
4
2003
151
0.080
Why?
Janus Kinase 1
1
2010
12
0.080
Why?
Cyclophosphamide
4
2003
176
0.080
Why?
Anemia
1
2010
75
0.080
Why?
MAP Kinase Kinase 1
1
2010
22
0.080
Why?
Antineoplastic Agents, Hormonal
2
2007
56
0.080
Why?
Cyclin-Dependent Kinases
1
2010
26
0.080
Why?
Administration, Oral
2
2009
455
0.080
Why?
Proteinuria
1
2010
40
0.080
Why?
Genomics
2
2023
266
0.080
Why?
Alleles
2
2021
279
0.080
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
83
0.080
Why?
Diphosphonates
1
2010
92
0.080
Why?
Dose-Response Relationship, Drug
3
2008
1365
0.080
Why?
Lorazepam
1
2009
13
0.080
Why?
Receptors, Retinoic Acid
1
2009
22
0.080
Why?
Hyperhomocysteinemia
1
2009
29
0.080
Why?
Oxycodone
1
2009
26
0.080
Why?
Anesthesia, Local
1
2009
18
0.080
Why?
Prednisone
1
2009
100
0.080
Why?
Histones
2
2021
315
0.070
Why?
Tretinoin
1
2009
53
0.070
Why?
Hemostatic Techniques
1
2009
31
0.070
Why?
Plasma Exchange
1
2009
25
0.070
Why?
Transcription Factors
2
2023
570
0.070
Why?
Vasculitis
1
2008
28
0.070
Why?
Vincristine
3
2003
89
0.070
Why?
Syndecan-1
3
2021
73
0.070
Why?
Biopsy
3
2018
594
0.070
Why?
Radiopharmaceuticals
2
2021
198
0.070
Why?
DNA Copy Number Variations
2
2021
116
0.070
Why?
Drug Therapy, Combination
1
2009
404
0.070
Why?
Cytogenetics
1
2008
23
0.070
Why?
Bone Development
1
2009
68
0.070
Why?
Staphylococcal Infections
2
2019
270
0.070
Why?
Carrier Proteins
1
2010
312
0.070
Why?
Pain Measurement
1
2009
263
0.070
Why?
Platelet Aggregation
1
2008
76
0.070
Why?
Thrombocytopenia
1
2009
93
0.070
Why?
Double-Blind Method
1
2009
726
0.070
Why?
Brain Diseases, Metabolic
1
2007
5
0.070
Why?
Phlebography
1
2007
54
0.070
Why?
Hyperammonemia
1
2007
23
0.070
Why?
Myeloma Proteins
1
2007
26
0.070
Why?
Antimetabolites
1
2006
12
0.070
Why?
Chi-Square Distribution
1
2007
292
0.060
Why?
Magnetic Resonance Imaging
4
2007
1507
0.060
Why?
Cell Communication
2
2023
74
0.060
Why?
Partial Thromboplastin Time
1
2006
14
0.060
Why?
Osteoprotegerin
1
2006
53
0.060
Why?
Acetaminophen
1
2009
272
0.060
Why?
Heterozygote
1
2006
89
0.060
Why?
Gastrointestinal Neoplasms
1
2006
41
0.060
Why?
Antibiotics, Antineoplastic
1
2006
83
0.060
Why?
Models, Statistical
1
2007
230
0.060
Why?
Pilot Projects
1
2008
725
0.060
Why?
Age Factors
3
2005
1120
0.060
Why?
Femur Head Necrosis
1
2005
17
0.060
Why?
Apoptosis
1
2010
1120
0.060
Why?
Neovascularization, Physiologic
1
2005
86
0.060
Why?
Gene Deletion
2
2003
279
0.060
Why?
Syndrome
2
2019
247
0.060
Why?
ROC Curve
1
2025
249
0.060
Why?
Killer Cells, Natural
1
2024
111
0.050
Why?
Ferritins
1
2024
36
0.050
Why?
DNA Methylation
2
2020
573
0.050
Why?
Glucuronidase
1
2003
47
0.050
Why?
Myeloid Progenitor Cells
1
2023
15
0.050
Why?
X-Ray Microtomography
1
2024
79
0.050
Why?
CD8-Positive T-Lymphocytes
1
2024
140
0.050
Why?
Receptors, G-Protein-Coupled
1
2024
57
0.050
Why?
DNA, Neoplasm
2
2020
146
0.050
Why?
Antibodies
1
2024
144
0.050
Why?
Immunosuppressive Agents
1
2005
248
0.050
Why?
Oligonucleotide Array Sequence Analysis
4
2006
412
0.050
Why?
Discitis
1
2003
10
0.050
Why?
Myeloproliferative Disorders
1
2003
32
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Antigens, CD34
1
2003
73
0.050
Why?
Tumor Cells, Cultured
3
2010
441
0.050
Why?
Rats
1
2009
3228
0.050
Why?
Platelet Count
3
2008
78
0.050
Why?
Patients
1
2022
50
0.050
Why?
Geography
1
2022
65
0.050
Why?
Leukemia, Myeloid
1
2002
41
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
32
0.050
Why?
Receptors, Antigen, T-Cell
1
2022
48
0.050
Why?
Drug Interactions
1
2002
198
0.050
Why?
Chromosome Disorders
1
2002
32
0.050
Why?
United States Food and Drug Administration
1
2022
89
0.050
Why?
Patient Selection
1
2023
269
0.050
Why?
Enzyme Inhibitors
1
2004
378
0.040
Why?
Oncogenes
1
2021
61
0.040
Why?
Phylogeny
1
2022
229
0.040
Why?
Hypothyroidism
1
2002
56
0.040
Why?
Central Nervous System Neoplasms
1
2002
69
0.040
Why?
RANK Ligand
1
2022
188
0.040
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
90
0.040
Why?
Transcriptional Activation
1
2021
127
0.040
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
108
0.040
Why?
Cohort Studies
2
2020
1576
0.040
Why?
Chromatin
1
2021
143
0.040
Why?
Antibodies, Monoclonal, Humanized
1
2022
230
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
67
0.040
Why?
Pyrimidines
1
2022
199
0.040
Why?
Cyclin D2
1
2020
21
0.040
Why?
Aneuploidy
1
2020
19
0.040
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
Endothelium, Vascular
1
2002
263
0.040
Why?
ras Proteins
1
2020
62
0.040
Why?
Histone Code
1
2020
32
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
31
0.040
Why?
Cyclin D1
1
2020
59
0.040
Why?
Genome, Human
1
2021
121
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
76
0.040
Why?
Longitudinal Studies
2
2016
756
0.040
Why?
Transcriptional Elongation Factors
1
2020
17
0.040
Why?
Protein Kinase Inhibitors
1
2022
231
0.040
Why?
Genetic Loci
1
2020
46
0.040
Why?
Postoperative Complications
1
2007
1065
0.040
Why?
DNA Mutational Analysis
1
2020
179
0.040
Why?
RNA, Messenger
3
2010
1134
0.040
Why?
Genetic Variation
1
2020
226
0.040
Why?
Neoplastic Stem Cells
2
2015
88
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
178
0.040
Why?
Health Status Disparities
1
2022
218
0.040
Why?
Computational Biology
1
2020
209
0.040
Why?
Gram-Positive Bacterial Infections
1
2019
29
0.040
Why?
Pseudomonas Infections
1
2019
55
0.040
Why?
Proline
1
2018
31
0.040
Why?
DNA-Binding Proteins
1
2021
423
0.040
Why?
Bone Marrow Cells
2
2014
188
0.040
Why?
Promoter Regions, Genetic
1
2020
465
0.040
Why?
Recombinant Proteins
2
2010
490
0.040
Why?
Fluorescent Dyes
1
2018
91
0.040
Why?
Proteolysis
1
2018
100
0.030
Why?
Receptor Protein-Tyrosine Kinases
1
2018
51
0.030
Why?
Oncogene Proteins, Fusion
1
2018
61
0.030
Why?
Extracellular Matrix
1
2018
116
0.030
Why?
Kidney Function Tests
1
2017
56
0.030
Why?
Cell Movement
1
2018
271
0.030
Why?
False Positive Reactions
1
2017
64
0.030
Why?
Glomerular Filtration Rate
1
2017
126
0.030
Why?
Amino Acid Sequence
1
2018
576
0.030
Why?
Genetic Predisposition to Disease
1
2020
525
0.030
Why?
Cell Survival
2
2010
598
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Mice, SCID
2
2009
178
0.030
Why?
Genes, p53
1
2016
50
0.030
Why?
Glycolysis
1
2016
70
0.030
Why?
Chromosome Mapping
2
2006
149
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
96
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
147
0.030
Why?
Serum Albumin
2
2008
57
0.030
Why?
Syndecans
2
2006
37
0.030
Why?
Proteoglycans
2
2006
86
0.030
Why?
Cells, Cultured
1
2018
1583
0.030
Why?
Drug Monitoring
1
2015
81
0.030
Why?
Interspersed Repetitive Sequences
1
2014
7
0.030
Why?
Myocardium
1
2017
471
0.030
Why?
Karyotype
1
2014
18
0.030
Why?
Proportional Hazards Models
2
2006
446
0.030
Why?
Membrane Glycoproteins
2
2006
239
0.030
Why?
Transplantation Chimera
2
2003
16
0.020
Why?
Neoplasm Staging
2
2007
768
0.020
Why?
Infusions, Intravenous
2
2003
212
0.020
Why?
RNA Interference
1
2013
183
0.020
Why?
Cytomegalovirus
1
2012
32
0.020
Why?
Viral Load
1
2012
81
0.020
Why?
Virus Activation
1
2012
39
0.020
Why?
Graft vs Host Disease
2
2003
91
0.020
Why?
United States
1
2022
5215
0.020
Why?
Interferon Regulatory Factor-1
1
2010
14
0.020
Why?
Cell Growth Processes
1
2010
24
0.020
Why?
Antiviral Agents
1
2012
173
0.020
Why?
CDC2-CDC28 Kinases
1
2010
11
0.020
Why?
Femur
1
2010
132
0.020
Why?
Long-Term Care
1
2010
50
0.020
Why?
RNA, Small Interfering
1
2010
217
0.020
Why?
Peripheral Nervous System Diseases
1
2010
61
0.020
Why?
Down-Regulation
1
2010
348
0.020
Why?
Bone Diseases, Metabolic
1
2010
80
0.020
Why?
Abnormalities, Multiple
1
2010
164
0.020
Why?
Cell Transformation, Neoplastic
1
2010
187
0.020
Why?
Protein Isoforms
1
2009
127
0.020
Why?
Ploidies
1
2008
10
0.020
Why?
Ligands
1
2009
205
0.020
Why?
Rabbits
1
2009
370
0.020
Why?
Polyethylene Glycols
1
2008
93
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
580
0.020
Why?
Hemoglobins
1
2008
114
0.020
Why?
Age Distribution
1
2007
176
0.020
Why?
Diagnosis, Differential
1
2010
1028
0.020
Why?
C-Reactive Protein
1
2008
151
0.020
Why?
Mass Screening
1
2010
354
0.020
Why?
Ammonia
1
2007
87
0.020
Why?
Multigene Family
1
2006
49
0.020
Why?
Blood Proteins
1
2007
84
0.020
Why?
Brain
2
2007
1337
0.020
Why?
Bone Density
1
2009
396
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Cyclins
1
2006
38
0.020
Why?
Evidence-Based Medicine
1
2007
271
0.020
Why?
RNA, Neoplasm
1
2006
45
0.020
Why?
Radiography
1
2007
469
0.010
Why?
Coculture Techniques
1
2006
142
0.010
Why?
Leukemia, Myeloid, Acute
1
2007
202
0.010
Why?
Data Interpretation, Statistical
1
2006
166
0.010
Why?
Neoplasms, Experimental
1
2006
111
0.010
Why?
Interferon-alpha
1
2005
52
0.010
Why?
Survivors
1
2006
121
0.010
Why?
Mice, Transgenic
1
2006
566
0.010
Why?
Databases, Factual
1
2007
721
0.010
Why?
Monosomy
1
2003
5
0.010
Why?
Odds Ratio
1
2005
563
0.010
Why?
Trisomy
1
2003
35
0.010
Why?
History, 21st Century
1
2003
60
0.010
Why?
Endothelial Growth Factors
1
2003
11
0.010
Why?
Vascular Endothelial Growth Factors
1
2003
15
0.010
Why?
Lymphokines
1
2003
20
0.010
Why?
Fusion Proteins, bcr-abl
1
2003
20
0.010
Why?
Stem Cell Factor
1
2003
7
0.010
Why?
History, 20th Century
1
2003
100
0.010
Why?
Confidence Intervals
1
2003
158
0.010
Why?
Interphase
1
2003
9
0.010
Why?
Lymphocyte Transfusion
1
2003
10
0.010
Why?
Probability
1
2003
171
0.010
Why?
Diploidy
1
2003
25
0.010
Why?
Leukocyte Count
1
2003
71
0.010
Why?
Back Pain
1
2003
39
0.010
Why?
Interferons
1
2002
38
0.010
Why?
Sex Factors
1
2005
735
0.010
Why?
Cell Count
1
2003
143
0.010
Why?
Intercellular Signaling Peptides and Proteins
1
2003
106
0.010
Why?
Drug Administration Schedule
1
2003
370
0.010
Why?
Thyroid Function Tests
1
2002
27
0.010
Why?
Thyrotropin
1
2002
48
0.010
Why?
Prevalence
1
2005
1016
0.010
Why?
Neutrophils
1
2003
148
0.010
Why?
Fatal Outcome
1
2002
193
0.010
Why?
Tissue Donors
1
2003
126
0.010
Why?
Cell Division
1
2002
288
0.010
Why?
Reoperation
1
2003
463
0.010
Why?
Acute Disease
1
2002
384
0.010
Why?
Up-Regulation
1
2002
462
0.010
Why?
Anti-Bacterial Agents
1
2003
816
0.010
Why?
Zangari's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description